Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Toxicity: Dose-Dependent Reactions

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...

Proteomics

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...

Drug toxicity: Drug–Drug Interaction

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Untargeted metabolomics and lipidomics in COVID-19 patient plasma reveals disease severity biomarkers.

Metabolomics : Official journal of the Metabolomic Society·2024

Same author

Identification of Proteomic Biomarkers of Acetaminophen-Induced Hepatotoxicity Using Stable Isotope Labeling.

Methods in molecular biology (Clifton, N.J.)·2024

Same author

Phenotypic, genotypic and proteomic variations between poor and robust colonizing Campylobacter jejuni strains.

Microbial pathogenesis·2024

Same author

Current Practices in LC-MS Untargeted Metabolomics: A Scoping Review on the Use of Pooled Quality Control Samples.

Analytical chemistry·2023

Same author

Modeling Clinical Phenotype Variability: Consideration of Genomic Variations, Computational Methods, and Quantitative Proteomics.

Journal of pharmaceutical sciences·2022

Same author

Quality assurance and quality control reporting in untargeted metabolic phenotyping: mQACC recommendations for analytical quality management.

Metabolomics : Official journal of the Metabolomic Society·2022

Same journal

From consensus structure prediction to RNA gene finding.

Briefings in functional genomics & proteomics·2009

Same journal

The use of covariance models to annotate RNAs in whole genomes.

Briefings in functional genomics & proteomics·2009

Same journal

Annotating non-coding transcription using functional genomics strategies.

Briefings in functional genomics & proteomics·2009

Same journal

Establishing legitimacy and function in the new transcriptome.

Briefings in functional genomics & proteomics·2009

Same journal

The role of RNA molecules in cellular biology. Editorial.

Briefings in functional genomics & proteomics·2009

Same journal

Sequencing genomes: from individuals to populations.

Briefings in functional genomics & proteomics·2009

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 24, 2026

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

Quantitative proteomics for drug toxicity.

Yuan Gao¹, Ricky D Holland, Li-Rong Yu

¹Division of Systems Toxicology, Center for Proteomics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR 72079, USA.

Briefings in Functional Genomics & Proteomics

|April 9, 2009

Summary

This summary is machine-generated.

Quantitative toxicoproteomics uses advanced proteomic technologies to study toxicity from various substances. This research aids in identifying drug toxicity biomarkers, targets, and mechanisms, advancing personalized medicine.

More Related Videos

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification

Published on: November 15, 2017

Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue

Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue

Published on: August 28, 2021

Related Experiment Videos

Last Updated: Jun 24, 2026

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification

Published on: November 15, 2017

Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue

Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue

Published on: August 28, 2021

Area of Science:

Toxicology
Proteomics
Drug Development

Background:

Toxicoproteomics studies the proteomic impact of toxic substances.
Drug safety is critical during development and clinical use.
Understanding toxicity mechanisms is essential for safe drug evaluation.

Purpose of the Study:

To highlight the role of quantitative proteomic technologies in toxicoproteomics.
To emphasize the application of toxicoproteomics in drug development and evaluation.
To explore the potential of quantitative proteomic approaches in personalized medicine.

Main Methods:

Quantitative proteomic technologies
Proteomic analysis of toxicological responses
Biomarker identification strategies

Main Results:

Quantitative proteomic technologies significantly advance toxicoproteomics.
Toxicoproteomics aids in identifying toxicity biomarkers and mechanisms.
These approaches are crucial for drug safety assessment.

Conclusions:

Quantitative toxicoproteomics is vital for understanding and mitigating toxicity.
Further development will enhance drug safety and personalized medicine.
This field offers significant potential for future medical advancements.